Cannara Biotech Inc. reported earnings results for the second quarter and six months ended February 28, 2022. For the second quarter, the company reported sales was CAD 0.827187 million compared to CAD 0.752457 million a year ago. Revenue was CAD 7.42 million compared to CAD 2.26 million a year ago. Net loss was CAD 1.15 million compared to CAD 0.862756 million a year ago.
For the six months, sales was CAD 1.73 million compared to CAD 1.31 million a year ago. Revenue was CAD 13.99 million compared to CAD 3.63 million a year ago. Net loss was CAD 1.68 million compared to CAD 4.36 million a year ago.